Trial
NCT06096181
Propofol + Remifentanil vs. Propofol + Dexmedetomidine in Adolescent Idiopathic Scoliosis Patients Having Spine Surgery
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Cedars-Sinai Medical Center
Collaborators
—
Condition
Adolescent Idiopathic Scoliosis
Intervention
Remifentanil TIVA
Why stopped
The primary surgeon decided to prematurely halt the study because he anecdotally felt that one of the trial drugs (Dexmedetomidine) could affect the motor evoked potential monitoring necessary for the surgery.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-10